BlackRock Inc. - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 32 filers reported holding ACER THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$62,570
-11.7%
76,7720.0%0.00%
Q2 2023$70,892
-9.2%
76,772
-25.4%
0.00%
Q1 2023$78,104
-73.9%
102,972
-13.5%
0.00%
Q4 2022$298,740
+80.0%
119,020
+0.2%
0.00%
Q3 2022$166,000
+9.9%
118,826
-1.1%
0.00%
Q2 2022$151,000
-49.7%
120,105
+16.6%
0.00%
Q1 2022$300,000
+26.6%
103,040
-1.2%
0.00%
Q4 2021$237,000
-10.6%
104,309
+0.7%
0.00%
Q3 2021$265,000
-11.4%
103,604
-0.5%
0.00%
Q2 2021$299,000
+2.7%
104,168
+11.2%
0.00%
Q1 2021$291,000
+18.8%
93,6380.0%0.00%
Q4 2020$245,000
-9.3%
93,6380.0%0.00%
Q3 2020$270,000
-52.9%
93,638
-43.9%
0.00%
Q2 2020$573,000
-26.1%
166,796
-57.2%
0.00%
Q1 2020$775,000
-50.8%
389,726
-0.8%
0.00%
Q4 2019$1,576,000
+23.4%
392,904
-1.9%
0.00%
Q3 2019$1,277,000
-1.2%
400,497
+20.8%
0.00%
Q2 2019$1,293,000
+166.6%
331,553
+1560.8%
0.00%
Q1 2019$485,000
+143.7%
19,963
+101.5%
0.00%
Q4 2018$199,000
-39.1%
9,908
-6.4%
0.00%
Q3 2018$327,000
+94.6%
10,591
+36.0%
0.00%
Q2 2018$168,000
+2300.0%
7,786
+2015.8%
0.00%
Q1 2018$7,000
+40.0%
3680.0%0.00%
Q4 2017$5,000
-28.6%
3680.0%0.00%
Q3 2017$7,0003680.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 250,518$722,0000.59%
Nantahala Capital Management 990,655$2,853,0000.09%
GSA CAPITAL PARTNERS LLP 82,421$237,0000.04%
FEDERATED HERMES, INC. 117,673$339,0000.00%
BNP PARIBAS FINANCIAL MARKETS 179$516,0000.00%
Horan Securities, Inc. 24$00.00%
OSAIC HOLDINGS, INC. 200$1,0000.00%
BANK OF AMERICA CORP /DE/ 3$00.00%
WELLS FARGO & COMPANY/MN 29$00.00%
NORTHERN TRUST CORP 31,083$90,0000.00%
View complete list of ACER THERAPEUTICS INC shareholders